Preferred Label : ripretinib;

MeSH Hyperonym : Urea, N-(4-bromo-5-(1-ethyl-1,2-dihydro-7-(methylamino)-2-oxo-1,6-naphthyridin-3-yl)-2-fluorophenyl)-N'-phenyl-;

UNII : 9XW757O13D;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3415645/fr/qinlock-ripretinib-tumeurs-stromales-gastro-intestinales
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Advanced Gastrointestinal Stromal Tumor
Refractory Malignant Gastrointestinal Stromal Tumor
antineoplastic agents
ripretinib
administration, oral
evaluation of the transparency committee
gastrointestinal stromal tumors
ripretinib

---
https://ansm.sante.fr/tableau-acces-derogatoire/ripretinib-50-mg-comprime
2024
false
false
false
France
French
administration, oral
ripretinib
ripretinib
drug information
gastrointestinal stromal tumors
Refractory Malignant Gastrointestinal Stromal Tumor
adult
antineoplastic agents

---
https://www.has-sante.fr/jcms/p_3318454/fr/qinlock-ripretinib
https://www.has-sante.fr/jcms/p_3318462/fr/decision-n-2022-0075/dc/sem-du-18-fevrier-2022-de-la-presidente-de-la-haute-autorite-de-sante-prise-au-nom-du-college-portant-autorisation-d-acces-precoce-de-la-specialite-qinlock
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
ripretinib
gastrointestinal stromal tumors
package leaflet
summary of product characteristics
Product containing precisely ripretinib 50 milligram/1 each conventional release oral tablet (clinical drug)
Refractory Neoplasm
guidelines for drug use
continuity of patient care
administration, oral
ripretinib
protein kinase inhibitors
protein kinase inhibitors
protein-tyrosine kinases
proto-oncogene proteins c-kit
receptor, platelet-derived growth factor alpha
Tyrosine Kinase Inhibitors
evaluation of the transparency committee
ripretinib

---
https://www.has-sante.fr/jcms/p_3324543/fr/qinlock-ripretinib-gist
2022
false
false
false
France
ripretinib
adult
ripretinib
administration, oral
Product containing precisely ripretinib 50 milligram/1 each conventional release oral tablet (clinical drug)
protein kinase inhibitors
protein kinase inhibitors
treatment outcome
insurance, health, reimbursement
Advanced Gastrointestinal Stromal Tumor
Unresectable Malignant Gastrointestinal Stromal Tumor
evaluation of the transparency committee
gastrointestinal stromal tumors
ripretinib

---
https://www.cadth.ca/fr/ripretinib
2021
false
false
false
Canada
French
English
drug evaluation
naphthyridines
urea
urea
ripretinib
gastrointestinal stromal tumors
canada

---
Nous contacter.
27/05/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.